{"id":"W3020802882","doi":"10.1016/j.jhep.2020.04.030","title":"Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum","year":2020,"lang":"en","type":"review","venue":"Journal of Hepatology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Target Real-world evidence; Abbott Molecular; Genentech; Ferring Pharmaceuticals; Madrigal Pharmaceuticals; NGM Biopharmaceuticals; Intercept Pharmaceuticals; Cirius Therapeutics; Zafgen; Chimerix; National Institutes of Health; Mylan; Quest Diagnostics; Arrowhead Pharmaceuticals; Ironwood Pharmaceuticals, Incorporated; Assembly Biosciences; Takeda Pharmaceuticals U.S.A.; AiCuris; Nordic Bioscience; AbbVie; Janssen Biotech; EA Pharma Co., Ltd.; Teva Pharmaceutical Industries; Novartis; Celgene; Galectin Therapeutics; Pfizer; Biogen; Gilead Sciences; Mallinckrodt Pharmaceuticals; Inventiva Pharma; Echosens; ViiV Healthcare; Astellas Pharma US; Shire; Syneos Health; Allergan; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Roivant Sciences; Boehringer Ingelheim; GlaxoSmithKline; Durect Corporation; HepQuant","keywords":"Clinical trial; Medicine; Fatty liver; Context (archaeology); Steatohepatitis; Disease; Alternative medicine; Psychological intervention; MEDLINE; Intensive care medicine; Physical therapy; Internal medicine; Pathology; Nursing; Political science","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03759388,0.001686535,0.01020095,0.003085208,0.000501238,0.00338001,0.00481397,0.00626302,0.004859594],"category_scores_gemma":[0.03894103,0.0008245481,0.006726499,0.002581372,0.001666888,0.002845183,0.001935675,0.007968958,0.001514702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002903604,"about_ca_system_score_gemma":0.009691561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003976485,"about_ca_topic_score_gemma":0.009209996,"domain_scores_codex":[0.9892454,0.00505232,0.002899165,0.0008116813,0.001655578,0.0003359591],"domain_scores_gemma":[0.965535,0.02369664,0.004012881,0.0007836089,0.0050597,0.0009121366],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002545869,0.0001429332,0.000357022,0.1609047,0.003785459,0.0001454615,0.0001836009,0.0005564733,0.0008872644,0.005833738,0.04977949,0.774878],"study_design_scores_gemma":[0.006186033,0.001072515,0.003985328,0.3319444,0.01757515,0.000458243,0.0002293265,0.0007559783,0.000712844,0.01195571,0.624966,0.0001586133],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001431899,0.988901,0.0007686141,0.007657661,0.00155909,0.0002166613,0.0001484035,0.00003921118,0.0005660836],"genre_scores_gemma":[0.003339935,0.9769035,0.006981184,0.01015231,0.001204389,0.0005885334,0.0002861661,0.00002790245,0.0005159818],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03759388,"threshold_uncertainty_score":0.1988178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2197601053258584,"score_gpt":0.4783652651535013,"score_spread":0.2586051598276429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}